Evaluation of pregnancy outcomes from the Tysabri® (natalizumab) pregnancy exposure registry: a global, observational, follow-up study

Normal outcome of pregnancy with ongoing treatment with natalizumab

(2014) J. Fagius et al.   ACTA NEUROLOGICA SCANDINAVICA

Final results from the Betaseron (interferon β-1b) Pregnancy Registry: a prospective observational study of birth defects and pregnancy-related adverse events

(2014) P K Coyle et al.   BMJ Open

Natalizumab Use During the Third Trimester of Pregnancy

(2014) Aiden Haghikia et al.   JAMA Neurology

Incidence of multiple sclerosis among European Economic Area populations, 1985-2009: the framework for monitoring

(2013) Enrique Alcalde-Cabero et al.   BMC Neurology

Multiple sclerosis and pregnancy: therapeutic considerations

(2012) Maria K. Houtchens et al.   JOURNAL OF NEUROLOGY

The Utility of Administrative Data for Surveillance of Comorbidity in Multiple Sclerosis: A Validation Study

(2012) Ruth Ann Marrie et al.   NEUROEPIDEMIOLOGY

Natalizumab

(2012) Richard Rudick et al.   JAMA Neurology

Multiple sclerosis and pregnancy

(2011) Alex Tsui et al.   CURRENT OPINION IN OBSTETRICS & GYNECOLOGY

Epidemiology and Natural History of Inflammatory Bowel Diseases

(2011) Jacques Cosnes et al.   GASTROENTEROLOGY

Age at onset as a determinant of presenting phenotype and initial relapse recovery in multiple sclerosis

(2011) M Cossburn et al.   Multiple Sclerosis Journal

Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizumab treatment

(2011) Kerstin Hellwig et al.   Multiple Sclerosis Journal

Delivery of healthy babies after natalizumab use for multiple sclerosis: a report of two cases

(2010) I. A. Hoevenaren et al.   ACTA NEUROLOGICA SCANDINAVICA

Comorbidities amongst patients with multiple sclerosis: a population-based controlled study

(2010) J.-H. Kang et al.   EUROPEAN JOURNAL OF NEUROLOGY

Embryo/fetal development in cynomolgus monkeys exposed to natalizumab, an α4 integrin inhibitor

(2009) Nancy G. Wehner et al.   BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY

Effects of natalizumab, an α4 integrin inhibitor, on fertility in male and female guinea pigs

(2009) Nancy G. Wehner et al.   BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY

Postnatal development in cynomolgus monkeys following prenatal exposure to natalizumab, an α4 integrin inhibitor

(2009) Nancy G. Wehner et al.   BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY

Effects of natalizumab, an α4 integrin inhibitor, on the development of Hartley guinea pigs

(2009) Nancy G. Wehner et al.   BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY

Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study

(2009) C Weber-Schoendorfer et al.   Multiple Sclerosis Journal

High frequency of adverse health behaviors in multiple sclerosis

(2008) RA Marrie et al.   Multiple Sclerosis Journal